1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Marx, U.C.
Craik, D.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
278
21782
10.1074/JBC.M212996200
12621047
Enzymatic Cyclization of a Potent Bowman-Birk Protease Inhibitor, Sunflower Trypsin Inhibitor-1, and Solution Structure of an Acyclic Precursor Peptide
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
ACYCLIC PERMUTANT OF SFTI-1, OPEN BETWEEN RESIDUES K5 AND S6
1535.829
CYCLIC TRYPSIN INHIBITOR
1
syn
polymer
SFTI-1
no
no
GRCTKSIPPICFPD
GRCTKSIPPICFPD
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2003-03-13
1
1
2011-05-08
1
2
2011-07-13
SOLUTION STRUCTURE OF SFTI-1,A CYCLIC TRYPSIN INHIBITOR FROM SUNFLOWER SEEDS
SOLUTION STRUCTURE OF SFTI-1(14,1),AN ACYCLIC PERMUTANT OF THE PROTEINASE INHIBITOR SFTI-1
SOLUTION STRUCTURE OF SFTI-1(6,5), AN ACYCLIC PERMUTANT OF THE PROTEINASE INHIBITOR SFTI-1,TRANS-TRANS-TRANS CONFORMER (TT-A)
HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS
PDBE
Y
PDBE
2002-12-09
REL
4232
SUNFLOWER
HELIANTHUS ANNUUS L.
sample
THE NUMBERING SCHEME FOLLOWED IN THIS ENTRY CONFORMS TO
THE ORDER DESCRIBED IN PDB ENTRY 1JBL.
LEAST OVERALL ENERGIES
50
20
NOESY
COSY
TOCSY
0.04
4.5
pH
1
atm
286
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
simulated annealing
1
90% H2O/10% D2O
100% D2O
BRUNGER
refinement
X-PLOR3.851
structure solution
NDEE
structure solution
XPLOR
750
Bruker
DMX
GLY
1
n
1
GLY
1
A
ARG
2
n
2
ARG
2
A
CYS
3
n
3
CYS
3
A
THR
4
n
4
THR
4
A
LYS
5
n
5
LYS
5
A
SER
6
n
6
SER
6
A
ILE
7
n
7
ILE
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
PHE
12
n
12
PHE
12
A
PRO
13
n
13
PRO
13
A
ASP
14
n
14
ASP
14
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
PHE
12
A
N
PHE
12
A
O
ARG
2
A
O
ARG
2
1
A
A
N
C
GLY
ASP
1
14
1.31
2
A
A
N
C
GLY
ASP
1
14
1.31
3
A
A
N
C
GLY
ASP
1
14
1.31
4
A
A
N
C
GLY
ASP
1
14
1.30
5
A
A
N
C
GLY
ASP
1
14
1.31
6
A
A
N
C
GLY
ASP
1
14
1.30
7
A
A
N
C
GLY
ASP
1
14
1.30
8
A
A
N
C
GLY
ASP
1
14
1.31
9
A
A
N
C
GLY
ASP
1
14
1.30
10
A
A
N
C
GLY
ASP
1
14
1.30
11
A
A
N
C
GLY
ASP
1
14
1.30
12
A
A
N
C
GLY
ASP
1
14
1.30
12
A
A
N
O
GLY
ASP
1
14
2.19
13
A
A
N
C
GLY
ASP
1
14
1.30
13
A
A
N
O
GLY
ASP
1
14
2.19
14
A
A
N
C
GLY
ASP
1
14
1.31
15
A
A
N
C
GLY
ASP
1
14
1.31
16
A
A
N
C
GLY
ASP
1
14
1.30
17
A
A
N
C
GLY
ASP
1
14
1.30
17
A
A
HZ3
O
LYS
SER
5
6
1.58
18
A
A
N
C
GLY
ASP
1
14
1.30
19
A
A
N
C
GLY
ASP
1
14
1.31
20
A
A
N
C
GLY
ASP
1
14
1.30
20
A
A
OG1
H2
THR
SER
4
6
1.58
1
A
ARG
2
0.300
SIDE CHAIN
2
A
ARG
2
0.163
SIDE CHAIN
3
A
ARG
2
0.098
SIDE CHAIN
4
A
ARG
2
0.285
SIDE CHAIN
5
A
ARG
2
0.279
SIDE CHAIN
6
A
ARG
2
0.135
SIDE CHAIN
7
A
ARG
2
0.180
SIDE CHAIN
8
A
ARG
2
0.083
SIDE CHAIN
9
A
ARG
2
0.243
SIDE CHAIN
10
A
ARG
2
0.286
SIDE CHAIN
11
A
ARG
2
0.223
SIDE CHAIN
12
A
ARG
2
0.309
SIDE CHAIN
13
A
ARG
2
0.307
SIDE CHAIN
14
A
ARG
2
0.295
SIDE CHAIN
15
A
ARG
2
0.279
SIDE CHAIN
16
A
ARG
2
0.175
SIDE CHAIN
17
A
ARG
2
0.184
SIDE CHAIN
18
A
ARG
2
0.280
SIDE CHAIN
19
A
ARG
2
0.245
SIDE CHAIN
20
A
ARG
2
0.284
SIDE CHAIN
1
A
A
C
N
LYS
SER
5
6
6.48
2
A
A
C
N
LYS
SER
5
6
6.64
3
A
A
C
N
LYS
SER
5
6
5.74
4
A
A
C
N
LYS
SER
5
6
6.62
5
A
A
C
N
LYS
SER
5
6
6.87
6
A
A
C
N
LYS
SER
5
6
6.67
7
A
A
C
N
LYS
SER
5
6
9.18
8
A
A
C
N
LYS
SER
5
6
10.29
9
A
A
C
N
LYS
SER
5
6
7.27
10
A
A
C
N
LYS
SER
5
6
5.30
11
A
A
C
N
LYS
SER
5
6
6.13
12
A
A
C
N
LYS
SER
5
6
9.78
13
A
A
C
N
LYS
SER
5
6
5.41
14
A
A
C
N
LYS
SER
5
6
8.71
15
A
A
C
N
LYS
SER
5
6
4.80
16
A
A
C
N
LYS
SER
5
6
8.01
17
A
A
C
N
LYS
SER
5
6
9.09
18
A
A
C
N
LYS
SER
5
6
5.69
19
A
A
C
N
LYS
SER
5
6
7.47
20
A
A
C
N
LYS
SER
5
6
4.11
2
A
ILE
7
-172.45
93.23
4
A
ILE
7
-173.24
94.42
13
A
ILE
7
-173.13
93.87
14
A
ILE
7
-171.55
92.82
17
A
ILE
7
-162.49
93.55
CYCLIC TRYPSIN INHIBITOR
Solution structure of SFTI-1(6,5), an acyclic permutant of the proteinase inhibitor SFTI-1, cis-trans-trans conformer (ct-A)
1
N
N
disulf
2.020
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
11
A
SG
CYS
11
1_555
PROTEASE INHIBITOR
PROTEASE INHIBITOR, BOWMAN-BIRK INHIBITOR, SFTI-1, ACYCLIC PERMUTANT
A
ILE
7
A
ILE
7
1
A
PRO
8
A
PRO
8
0.01
A
ILE
7
A
ILE
7
2
A
PRO
8
A
PRO
8
-0.06
A
ILE
7
A
ILE
7
3
A
PRO
8
A
PRO
8
-0.04
A
ILE
7
A
ILE
7
4
A
PRO
8
A
PRO
8
0.01
A
ILE
7
A
ILE
7
5
A
PRO
8
A
PRO
8
-0.10
A
ILE
7
A
ILE
7
6
A
PRO
8
A
PRO
8
0.01
A
ILE
7
A
ILE
7
7
A
PRO
8
A
PRO
8
0.04
A
ILE
7
A
ILE
7
8
A
PRO
8
A
PRO
8
0.01
A
ILE
7
A
ILE
7
9
A
PRO
8
A
PRO
8
-0.17
A
ILE
7
A
ILE
7
10
A
PRO
8
A
PRO
8
-0.07
A
ILE
7
A
ILE
7
11
A
PRO
8
A
PRO
8
-0.04
A
ILE
7
A
ILE
7
12
A
PRO
8
A
PRO
8
0.00
A
ILE
7
A
ILE
7
13
A
PRO
8
A
PRO
8
0.07
A
ILE
7
A
ILE
7
14
A
PRO
8
A
PRO
8
0.18
A
ILE
7
A
ILE
7
15
A
PRO
8
A
PRO
8
0.11
A
ILE
7
A
ILE
7
16
A
PRO
8
A
PRO
8
0.01
A
ILE
7
A
ILE
7
17
A
PRO
8
A
PRO
8
-0.04
A
ILE
7
A
ILE
7
18
A
PRO
8
A
PRO
8
0.00
A
ILE
7
A
ILE
7
19
A
PRO
8
A
PRO
8
-0.06
A
ILE
7
A
ILE
7
20
A
PRO
8
A
PRO
8
-0.03
1O8Z
PDB
1
1O8Z
6
14
1O8Z
6
14
1O8Z
A
1
6
14
1
5
1O8Z
1
5
1O8Z
A
1
1
5
2
anti-parallel
A
CYS
11
A
CYS
11
A
PHE
12
A
PHE
12
A
ARG
2
A
ARG
2
A
CYS
3
A
CYS
3
1
P 1